207 related articles for article (PubMed ID: 36808431)
21. Tandem bromodomains in the chromatin remodeler RSC recognize acetylated histone H3 Lys14.
Kasten M; Szerlong H; Erdjument-Bromage H; Tempst P; Werner M; Cairns BR
EMBO J; 2004 Mar; 23(6):1348-59. PubMed ID: 15014446
[TBL] [Abstract][Full Text] [Related]
22. BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Piva F; Santoni M; Matrana MR; Satti S; Giulietti M; Occhipinti G; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Principato G; Cascinu S; Montironi R
Expert Rev Mol Diagn; 2015; 15(9):1201-10. PubMed ID: 26166446
[TBL] [Abstract][Full Text] [Related]
23. Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.
Olp MD; Zhu N; Smith BC
Biochemistry; 2017 Oct; 56(41):5485-5495. PubMed ID: 28945351
[TBL] [Abstract][Full Text] [Related]
24. DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.
Morrison EA; Sanchez JC; Ronan JL; Farrell DP; Varzavand K; Johnson JK; Gu BX; Crabtree GR; Musselman CA
Nat Commun; 2017 Jul; 8():16080. PubMed ID: 28706277
[TBL] [Abstract][Full Text] [Related]
25. Heterologous expression of the human polybromo-1 protein in the methylotrophic yeast Pichia pastoris.
Hopson SE; Thompson MJ
Protein Expr Purif; 2018 Dec; 152():23-30. PubMed ID: 30009957
[TBL] [Abstract][Full Text] [Related]
26. Binding specificity and function of the SWI/SNF subunit SMARCA4 bromodomain interaction with acetylated histone H3K14.
Enríquez P; Krajewski K; Strahl BD; Rothbart SB; Dowen RH; Rose RB
J Biol Chem; 2021 Oct; 297(4):101145. PubMed ID: 34473995
[TBL] [Abstract][Full Text] [Related]
27. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.
Nargund AM; Pham CG; Dong Y; Wang PI; Osmangeyoglu HU; Xie Y; Aras O; Han S; Oyama T; Takeda S; Ray CE; Dong Z; Berge M; Hakimi AA; Monette S; Lekaye CL; Koutcher JA; Leslie CS; Creighton CJ; Weinhold N; Lee W; Tickoo SK; Wang Z; Cheng EH; Hsieh JJ
Cell Rep; 2017 Mar; 18(12):2893-2906. PubMed ID: 28329682
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic analysis of acetylation-dependent Pb1 bromodomain-histone H3 interactions.
Thompson M; Chandrasekaran R
Anal Biochem; 2008 Mar; 374(2):304-12. PubMed ID: 18191465
[TBL] [Abstract][Full Text] [Related]
29. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N; Morimoto Y; Fushimi A; Ahmad R; Bhattacharya A; Daimon T; Haratake N; Inoue Y; Ishikawa S; Yamamoto M; Hata T; Akiyoshi S; Hu Q; Liu T; Withers H; Liu S; Shapiro GI; Yoshizumi T; Long MD; Kufe D
Mol Cancer Res; 2023 Mar; 21(3):274-289. PubMed ID: 36445328
[TBL] [Abstract][Full Text] [Related]
30. The Structural Basis for Specific Recognition of H3K14 Acetylation by Sth1 in the RSC Chromatin Remodeling Complex.
Chen G; Li W; Yan F; Wang D; Chen Y
Structure; 2020 Jan; 28(1):111-118.e3. PubMed ID: 31711754
[TBL] [Abstract][Full Text] [Related]
31. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
[TBL] [Abstract][Full Text] [Related]
32. PBRM1 Regulates Stress Response in Epithelial Cells.
Porter EG; Dhiman A; Chowdhury B; Carter BC; Lin H; Stewart JC; Kazemian M; Wendt MK; Dykhuizen EC
iScience; 2019 May; 15():196-210. PubMed ID: 31077944
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
Gossage L; Murtaza M; Slatter AF; Lichtenstein CP; Warren A; Haynes B; Marass F; Roberts I; Shanahan SJ; Claas A; Dunham A; May AP; Rosenfeld N; Forshew T; Eisen T
Genes Chromosomes Cancer; 2014 Jan; 53(1):38-51. PubMed ID: 24166983
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.
Jiang W; Dulaimi E; Devarajan K; Parsons T; Wang Q; Liao L; Cho EA; O'Neill R; Solomides C; Peiper SC; Testa JR; Uzzo R; Yang H
PLoS One; 2016; 11(10):e0164554. PubMed ID: 27764136
[TBL] [Abstract][Full Text] [Related]
35. Histone H3 lysine 14 (H3K14) acetylation facilitates DNA repair in a positioned nucleosome by stabilizing the binding of the chromatin Remodeler RSC (Remodels Structure of Chromatin).
Duan MR; Smerdon MJ
J Biol Chem; 2014 Mar; 289(12):8353-63. PubMed ID: 24515106
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
Ibragimova I; Maradeo ME; Dulaimi E; Cairns P
Epigenetics; 2013 May; 8(5):486-93. PubMed ID: 23644518
[TBL] [Abstract][Full Text] [Related]
37. Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation.
VanDemark AP; Kasten MM; Ferris E; Heroux A; Hill CP; Cairns BR
Mol Cell; 2007 Sep; 27(5):817-28. PubMed ID: 17803945
[TBL] [Abstract][Full Text] [Related]
38. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.
Kapur P; Peña-Llopis S; Christie A; Zhrebker L; Pavía-Jiménez A; Rathmell WK; Xie XJ; Brugarolas J
Lancet Oncol; 2013 Feb; 14(2):159-167. PubMed ID: 23333114
[TBL] [Abstract][Full Text] [Related]
39. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
Singh M; Popowicz GM; Krajewski M; Holak TA
Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
[TBL] [Abstract][Full Text] [Related]
40. PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth.
Cai W; Su L; Liao L; Liu ZZ; Langbein L; Dulaimi E; Testa JR; Uzzo RG; Zhong Z; Jiang W; Yan Q; Zhang Q; Yang H
Nat Commun; 2019 Dec; 10(1):5800. PubMed ID: 31863007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
